New White Paper Analyzes Launches Since the Start of the COVID Pandemic to Profile Key Strategies that Improve Commercialization Success
Waltham, MA, October 2, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the availability of Trinity Launch Accelerator 2.0 to provide smart, efficient launch planning with customized, tech-enabled support. Built and powered by Trinity’s Launch Center of Excellence (COE), Launch Accelerator 2.0 is an easy-to-use cloud-based project management tool that leverages recent “real world”…
Waltham, MA, September 20, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, has announced its Board of Advisors, a group of independent, expert advisors that will help advance Trinity’s mission.
The Board of Advisors includes:
Susan DenmanMs. Denman is formerly with Johnson & Johnson where she held senior management roles including WW Vice President of Transfusion Medicine, WW VP of Innovation for Ortho Clinical Diagnostics, WW VP for the $2.4B Johnson’s Baby business, WW VP of…
Waltham, MA, August 23, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, was identified as a Sample Vendor in four sections within the July 2023 Gartner Hype Cycle for Life Sciences Commercial Operations report. The sections where Trinity was named are:
AI (Artificial Intelligence) in Commercial Operations
Advanced Decision Support for Sales
Personalization Engines in LS (Life Science)
D&A (Data & Analytics) Platforms in Commercial LS
As Gartner explains: “Life science organizations strive to balance…
Waltham, MA, August 16, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the creation of the Trinity Healthcheck suite to identify areas of opportunity and provide comprehensive, actionable recommendations for enhancing overall readiness and performance. The assessments objectively evaluate the current state of a life sciences company’s operations, including strategy, processes, technology and talent. The suite includes three types of assessments with the following areas of focus and recommendation:
Artificial Intelligence & Machine Learning…
Waltham, MA, August 15, 2023 — Inc. revealed today that Trinity Life Sciences, a leader in global life sciences commercialization solutions, was named to the Inc. 5000 list for the third year in a row. The prestigious ranking provides a data-driven look at the most successful companies within the economy’s most dynamic segment – its independent, entrepreneurial businesses.
“We are thrilled to again be named to the Inc. 5000 list of fastest growing private companies in America,” said Leslie Orne,…
Trinity Annual Drug Index Now Available
Waltham, MA, July 18, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the availability of its Trinity Annual Drug Index, an evaluation of the actual commercial performances over 3 years of 53 novel drugs approved in 2019.
This year’s report, the fifth in Trinity’s Drug Index series, outlines key themes and emerging trends as the life sciences industry moves towards a new world of targeted and innovative products. Scoring…
Upcoming Demo Maps Out an Enterprise-Wide Approach to Delivering Meaningful Competitive Insights that Shape Strategy
Waltham, MA, July 13, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the launch of the Market Intelligence Dashboard to meet the needs of Competitive Intelligence (CI) teams and their end users. Built and powered by Trinity’s Dynamic Market Intelligence Center of Excellence (COE), the Market Intelligence Dashboard provides a steady stream of curated data and insights through the…
David Fitzhenry to Remain a Strategic Advisor and Board Member
Waltham, MA, June 7, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced today the appointment of Leslie Orne as Chief Executive Officer (CEO) effective July 1. Ms. Orne, who is currently the President and Chief Commercial Officer at Trinity, succeeds David Fitzhenry, who has held various leadership roles at Trinity for 26 years. Mr. Fitzhenry will remain active with the Company as a strategic advisor…
Waltham, MA, May 30, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the winners of the TGaS Best of Benchmark (BoBs) Awards. The Awards, which are given for operational excellence within the pharmaceutical industry, were presented to teams at Bayer, Genentech, Novo Nordisk, Sanofi, Sunovion and UCB. The BoBs are based on TGaS benchmarking of large, midsize and emerging life sciences companies.
While the specific BoB criteria subtly changes from function to function, the…
Upcoming “Virtual Lunch and Learn” Examines Ways to Unlock Forecasting Value with Trinity CloudCast’s Technology
Waltham, MA, May 24, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces enhancements to its cross-functional forecasting tool, Trinity CloudCast™. Forecasting within life sciences companies is a collaborative exercise driving vital decisions that impact both the near- and long-term future of organizations in their entirety. CloudCast is an online solution that establishes structured data and information flows to support…